New radioactive injection targets Hard-to-Treat breast cancer
Disease control
Recruiting now
This early-phase trial tests the safety of a new radioactive drug, 225Ac-TR2205, in 15 women with advanced triple-negative breast cancer that has spread. The study aims to see if the treatment is tolerable and to measure how radiation moves through the body. It is not a cure, but…
Phase: EARLY_PHASE1 • Sponsor: Xiaorong Sun • Aim: Disease control
Last updated May 19, 2026 11:59 UTC